MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 72 filers reported holding MARKER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,190 | -30.2% | 15,758 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | +20.0% | 15,758 | 0.0% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 15,758 | 0.0% | 0.00% | – |
| Q1 2022 | $7,000 | -53.3% | 15,758 | 0.0% | 0.00% | – |
| Q4 2021 | $15,000 | -44.4% | 15,758 | +0.0% | 0.00% | – |
| Q3 2021 | $27,000 | -38.6% | 15,757 | 0.0% | 0.00% | – |
| Q2 2021 | $44,000 | -74.7% | 15,757 | -79.8% | 0.00% | – |
| Q1 2021 | $174,000 | +27.0% | 77,941 | -17.9% | 0.00% | – |
| Q4 2020 | $137,000 | -5.5% | 94,877 | -2.2% | 0.00% | – |
| Q3 2020 | $145,000 | -27.9% | 96,989 | 0.0% | 0.00% | – |
| Q2 2020 | $201,000 | +28.0% | 96,989 | +17.3% | 0.00% | – |
| Q1 2020 | $157,000 | -34.0% | 82,672 | 0.0% | 0.00% | – |
| Q4 2019 | $238,000 | -43.9% | 82,672 | -0.6% | 0.00% | – |
| Q3 2019 | $424,000 | -34.6% | 83,180 | +1.6% | 0.00% | – |
| Q2 2019 | $648,000 | +302.5% | 81,837 | +235.7% | 0.00% | – |
| Q1 2019 | $161,000 | +8.1% | 24,381 | -9.3% | 0.00% | – |
| Q4 2018 | $149,000 | – | 26,871 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AR ASSET MANAGEMENT INC | 70,700 | $321 | 0.09% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |